ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPI1
|
ENSG00000066336.7 | SPI1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SPI1 | hg19_v2_chr11_-_47399942_47399961, hg19_v2_chr11_-_47400078_47400127 | 0.76 | 5.8e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_46756351 | 12.92 |
ENST00000323076.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr1_+_198608146 | 11.93 |
ENST00000367376.2 ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
chr10_-_98031310 | 10.02 |
ENST00000427367.2 ENST00000413476.2 |
BLNK |
B-cell linker |
chr10_-_98031265 | 9.70 |
ENST00000224337.5 ENST00000371176.2 |
BLNK |
B-cell linker |
chr3_-_121379739 | 8.91 |
ENST00000428394.2 ENST00000314583.3 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
chr12_-_15114492 | 8.65 |
ENST00000541546.1 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
chr12_-_15114603 | 8.58 |
ENST00000228945.4 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
chr11_+_60223225 | 8.11 |
ENST00000524807.1 ENST00000345732.4 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_+_60223312 | 8.10 |
ENST00000532491.1 ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr1_-_207095324 | 7.93 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr2_+_33661382 | 7.53 |
ENST00000402538.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr17_-_62084241 | 7.40 |
ENST00000449662.2 |
ICAM2 |
intercellular adhesion molecule 2 |
chr1_-_183560011 | 7.20 |
ENST00000367536.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr1_+_111415757 | 6.98 |
ENST00000429072.2 ENST00000271324.5 |
CD53 |
CD53 molecule |
chr2_-_175499294 | 6.74 |
ENST00000392547.2 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr1_-_207095212 | 6.74 |
ENST00000420007.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr21_-_15918618 | 6.71 |
ENST00000400564.1 ENST00000400566.1 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
chr20_+_44746885 | 6.62 |
ENST00000372285.3 |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
chr14_-_23285011 | 6.29 |
ENST00000397532.3 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr15_-_80263506 | 6.16 |
ENST00000335661.6 |
BCL2A1 |
BCL2-related protein A1 |
chr14_-_23285069 | 6.10 |
ENST00000554758.1 ENST00000397528.4 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr1_-_183559693 | 5.86 |
ENST00000367535.3 ENST00000413720.1 ENST00000418089.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr8_+_56792355 | 5.81 |
ENST00000519728.1 |
LYN |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr20_+_44746939 | 5.79 |
ENST00000372276.3 |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
chr1_-_150738261 | 5.76 |
ENST00000448301.2 ENST00000368985.3 |
CTSS |
cathepsin S |
chr2_+_143886877 | 5.70 |
ENST00000295095.6 |
ARHGAP15 |
Rho GTPase activating protein 15 |
chr6_-_154677900 | 5.68 |
ENST00000265198.4 ENST00000520261.1 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
chr11_+_128563652 | 5.53 |
ENST00000527786.2 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr6_-_32160622 | 5.51 |
ENST00000487761.1 ENST00000375040.3 |
GPSM3 |
G-protein signaling modulator 3 |
chr4_-_40631859 | 5.32 |
ENST00000295971.7 ENST00000319592.4 |
RBM47 |
RNA binding motif protein 47 |
chr5_-_88178964 | 5.27 |
ENST00000513252.1 ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C |
myocyte enhancer factor 2C |
chr18_-_53177984 | 5.27 |
ENST00000543082.1 |
TCF4 |
transcription factor 4 |
chr5_-_169725231 | 5.25 |
ENST00000046794.5 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr12_+_25205568 | 5.17 |
ENST00000548766.1 ENST00000556887.1 |
LRMP |
lymphoid-restricted membrane protein |
chr12_+_25205666 | 5.14 |
ENST00000547044.1 |
LRMP |
lymphoid-restricted membrane protein |
chr8_+_56792377 | 5.13 |
ENST00000520220.2 |
LYN |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr1_-_25256368 | 5.09 |
ENST00000308873.6 |
RUNX3 |
runt-related transcription factor 3 |
chr17_-_29641104 | 5.01 |
ENST00000577894.1 ENST00000330927.4 |
EVI2B |
ecotropic viral integration site 2B |
chr15_+_81589254 | 5.00 |
ENST00000394652.2 |
IL16 |
interleukin 16 |
chr19_+_42381173 | 5.00 |
ENST00000221972.3 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr12_+_54891495 | 4.92 |
ENST00000293373.6 |
NCKAP1L |
NCK-associated protein 1-like |
chr12_+_7055767 | 4.87 |
ENST00000447931.2 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr12_+_7055631 | 4.86 |
ENST00000543115.1 ENST00000399448.1 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chrX_+_128913906 | 4.76 |
ENST00000356892.3 |
SASH3 |
SAM and SH3 domain containing 3 |
chr5_-_88179017 | 4.73 |
ENST00000514028.1 ENST00000514015.1 ENST00000503075.1 ENST00000437473.2 |
MEF2C |
myocyte enhancer factor 2C |
chr2_-_96811170 | 4.68 |
ENST00000288943.4 |
DUSP2 |
dual specificity phosphatase 2 |
chr1_-_111743285 | 4.64 |
ENST00000357640.4 |
DENND2D |
DENN/MADD domain containing 2D |
chr6_+_31543334 | 4.47 |
ENST00000449264.2 |
TNF |
tumor necrosis factor |
chr5_-_88179302 | 4.46 |
ENST00000504921.2 |
MEF2C |
myocyte enhancer factor 2C |
chr22_-_37545972 | 4.43 |
ENST00000216223.5 |
IL2RB |
interleukin 2 receptor, beta |
chr12_+_25205446 | 4.39 |
ENST00000557489.1 ENST00000354454.3 ENST00000536173.1 |
LRMP |
lymphoid-restricted membrane protein |
chr1_-_31230650 | 4.39 |
ENST00000294507.3 |
LAPTM5 |
lysosomal protein transmembrane 5 |
chr16_-_89043377 | 4.11 |
ENST00000436887.2 ENST00000448839.1 ENST00000360302.2 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr11_-_3862059 | 4.10 |
ENST00000396978.1 |
RHOG |
ras homolog family member G |
chr17_-_29641084 | 4.04 |
ENST00000544462.1 |
EVI2B |
ecotropic viral integration site 2B |
chr3_-_16555150 | 4.00 |
ENST00000334133.4 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr17_+_72462525 | 3.98 |
ENST00000360141.3 |
CD300A |
CD300a molecule |
chr5_+_169064245 | 3.98 |
ENST00000256935.8 |
DOCK2 |
dedicator of cytokinesis 2 |
chr17_-_38721711 | 3.90 |
ENST00000578085.1 ENST00000246657.2 |
CCR7 |
chemokine (C-C motif) receptor 7 |
chr19_+_42381337 | 3.77 |
ENST00000597454.1 ENST00000444740.2 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr16_-_89043605 | 3.70 |
ENST00000268679.4 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr17_-_34417479 | 3.68 |
ENST00000225245.5 |
CCL3 |
chemokine (C-C motif) ligand 3 |
chr11_-_3862206 | 3.64 |
ENST00000351018.4 |
RHOG |
ras homolog family member G |
chr19_+_49838653 | 3.57 |
ENST00000598095.1 ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37 |
CD37 molecule |
chr1_+_32716840 | 3.53 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr2_-_64371546 | 3.51 |
ENST00000358912.4 |
PELI1 |
pellino E3 ubiquitin protein ligase 1 |
chr4_+_68424434 | 3.49 |
ENST00000265404.2 ENST00000396225.1 |
STAP1 |
signal transducing adaptor family member 1 |
chr22_-_37640277 | 3.49 |
ENST00000401529.3 ENST00000249071.6 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_-_6481776 | 3.49 |
ENST00000543576.1 ENST00000590173.1 ENST00000381480.2 |
DENND1C |
DENN/MADD domain containing 1C |
chr17_+_72462766 | 3.48 |
ENST00000392625.3 ENST00000361933.3 ENST00000310828.5 |
CD300A |
CD300a molecule |
chrX_-_70331298 | 3.45 |
ENST00000456850.2 ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG |
interleukin 2 receptor, gamma |
chr16_+_30483962 | 3.44 |
ENST00000356798.6 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr1_+_32716857 | 3.30 |
ENST00000482949.1 ENST00000495610.2 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr22_-_37640456 | 3.22 |
ENST00000405484.1 ENST00000441619.1 ENST00000406508.1 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_+_32739733 | 3.21 |
ENST00000333070.4 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr18_-_53070913 | 3.20 |
ENST00000568186.1 ENST00000564228.1 |
TCF4 |
transcription factor 4 |
chr18_-_53068911 | 3.17 |
ENST00000537856.3 |
TCF4 |
transcription factor 4 |
chr11_+_128563948 | 3.14 |
ENST00000534087.2 |
FLI1 |
Fli-1 proto-oncogene, ETS transcription factor |
chr11_+_102188224 | 3.13 |
ENST00000263464.3 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chrX_+_78200913 | 3.07 |
ENST00000171757.2 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
chr9_+_2158485 | 3.04 |
ENST00000417599.1 ENST00000382185.1 ENST00000382183.1 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr11_+_102188272 | 3.04 |
ENST00000532808.1 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr9_+_2158443 | 3.01 |
ENST00000302401.3 ENST00000324954.5 ENST00000423555.1 ENST00000382186.1 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chrX_+_78200829 | 2.99 |
ENST00000544091.1 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
chr1_+_236305826 | 2.98 |
ENST00000366592.3 ENST00000366591.4 |
GPR137B |
G protein-coupled receptor 137B |
chr19_+_6772710 | 2.89 |
ENST00000304076.2 ENST00000602142.1 ENST00000596764.1 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
chr12_-_53601055 | 2.89 |
ENST00000552972.1 ENST00000422257.3 ENST00000267082.5 |
ITGB7 |
integrin, beta 7 |
chr12_-_53601000 | 2.86 |
ENST00000338737.4 ENST00000549086.2 |
ITGB7 |
integrin, beta 7 |
chr2_-_175462934 | 2.84 |
ENST00000392546.2 ENST00000436221.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr6_+_32811885 | 2.83 |
ENST00000458296.1 ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1 PSMB9 |
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr18_-_53069419 | 2.77 |
ENST00000570177.2 |
TCF4 |
transcription factor 4 |
chr8_-_82395461 | 2.76 |
ENST00000256104.4 |
FABP4 |
fatty acid binding protein 4, adipocyte |
chr11_-_58343319 | 2.75 |
ENST00000395074.2 |
LPXN |
leupaxin |
chr7_-_5569588 | 2.72 |
ENST00000417101.1 |
ACTB |
actin, beta |
chr15_+_75074410 | 2.71 |
ENST00000439220.2 |
CSK |
c-src tyrosine kinase |
chr22_+_37257015 | 2.65 |
ENST00000447071.1 ENST00000248899.6 ENST00000397147.4 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
chr3_-_105588231 | 2.60 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr1_+_161632937 | 2.58 |
ENST00000236937.9 ENST00000367961.4 ENST00000358671.5 |
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
chr3_+_142838091 | 2.56 |
ENST00000309575.3 |
CHST2 |
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
chr2_-_175462456 | 2.47 |
ENST00000409891.1 ENST00000410117.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr6_-_32811771 | 2.47 |
ENST00000395339.3 ENST00000374882.3 |
PSMB8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
chr15_+_75335604 | 2.46 |
ENST00000563393.1 |
PPCDC |
phosphopantothenoylcysteine decarboxylase |
chr14_-_23451467 | 2.46 |
ENST00000555074.1 ENST00000361265.4 |
RP11-298I3.5 AJUBA |
RP11-298I3.5 ajuba LIM protein |
chr19_-_10450328 | 2.41 |
ENST00000160262.5 |
ICAM3 |
intercellular adhesion molecule 3 |
chr18_-_52989217 | 2.36 |
ENST00000570287.2 |
TCF4 |
transcription factor 4 |
chr19_-_10450287 | 2.36 |
ENST00000589261.1 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr3_+_119316689 | 2.36 |
ENST00000273371.4 |
PLA1A |
phospholipase A1 member A |
chr15_+_75074385 | 2.32 |
ENST00000220003.9 |
CSK |
c-src tyrosine kinase |
chr10_+_12391481 | 2.32 |
ENST00000378847.3 |
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
chr18_-_52989525 | 2.31 |
ENST00000457482.3 |
TCF4 |
transcription factor 4 |
chr19_+_1077393 | 2.27 |
ENST00000590577.1 |
HMHA1 |
histocompatibility (minor) HA-1 |
chr4_+_103423055 | 2.25 |
ENST00000505458.1 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr6_+_31582961 | 2.25 |
ENST00000376059.3 ENST00000337917.7 |
AIF1 |
allograft inflammatory factor 1 |
chr1_-_184943610 | 2.24 |
ENST00000367511.3 |
FAM129A |
family with sequence similarity 129, member A |
chr1_-_202129704 | 2.22 |
ENST00000476061.1 ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
chr4_+_103422471 | 2.22 |
ENST00000226574.4 ENST00000394820.4 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr8_+_86089460 | 2.22 |
ENST00000418930.2 |
E2F5 |
E2F transcription factor 5, p130-binding |
chr17_-_20370847 | 2.21 |
ENST00000423676.3 ENST00000324290.5 |
LGALS9B |
lectin, galactoside-binding, soluble, 9B |
chrX_+_48542168 | 2.20 |
ENST00000376701.4 |
WAS |
Wiskott-Aldrich syndrome |
chr12_-_92539614 | 2.15 |
ENST00000256015.3 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
chr6_+_26156551 | 2.15 |
ENST00000304218.3 |
HIST1H1E |
histone cluster 1, H1e |
chr7_-_37488834 | 2.12 |
ENST00000310758.4 |
ELMO1 |
engulfment and cell motility 1 |
chr7_+_74188309 | 2.07 |
ENST00000289473.4 ENST00000433458.1 |
NCF1 |
neutrophil cytosolic factor 1 |
chr17_-_16875371 | 2.03 |
ENST00000437538.2 ENST00000583789.1 ENST00000261652.2 ENST00000579315.1 |
TNFRSF13B |
tumor necrosis factor receptor superfamily, member 13B |
chr3_-_98241358 | 1.98 |
ENST00000503004.1 ENST00000506575.1 ENST00000513452.1 ENST00000515620.1 |
CLDND1 |
claudin domain containing 1 |
chr2_+_198669365 | 1.98 |
ENST00000428675.1 |
PLCL1 |
phospholipase C-like 1 |
chr2_+_182321925 | 1.93 |
ENST00000339307.4 ENST00000397033.2 |
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr7_+_50344289 | 1.93 |
ENST00000413698.1 ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
chr1_-_154909329 | 1.91 |
ENST00000368467.3 |
PMVK |
phosphomevalonate kinase |
chr2_-_214016314 | 1.91 |
ENST00000434687.1 ENST00000374319.4 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
chr7_+_99971129 | 1.91 |
ENST00000394000.2 ENST00000350573.2 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
chr2_-_225811747 | 1.87 |
ENST00000409592.3 |
DOCK10 |
dedicator of cytokinesis 10 |
chr12_-_6233828 | 1.83 |
ENST00000572068.1 ENST00000261405.5 |
VWF |
von Willebrand factor |
chr3_+_119316721 | 1.83 |
ENST00000488919.1 ENST00000495992.1 |
PLA1A |
phospholipase A1 member A |
chr7_-_120498357 | 1.82 |
ENST00000415871.1 ENST00000222747.3 ENST00000430985.1 |
TSPAN12 |
tetraspanin 12 |
chr10_-_121302195 | 1.82 |
ENST00000369103.2 |
RGS10 |
regulator of G-protein signaling 10 |
chr22_+_40322595 | 1.80 |
ENST00000420971.1 ENST00000544756.1 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr22_+_40322623 | 1.78 |
ENST00000399090.2 |
GRAP2 |
GRB2-related adaptor protein 2 |
chr11_+_19138670 | 1.78 |
ENST00000446113.2 ENST00000399351.3 |
ZDHHC13 |
zinc finger, DHHC-type containing 13 |
chr1_-_226926864 | 1.77 |
ENST00000429204.1 ENST00000366784.1 |
ITPKB |
inositol-trisphosphate 3-kinase B |
chr8_+_86089619 | 1.76 |
ENST00000256117.5 ENST00000416274.2 |
E2F5 |
E2F transcription factor 5, p130-binding |
chr4_+_106629929 | 1.75 |
ENST00000512828.1 ENST00000394730.3 ENST00000507281.1 ENST00000515279.1 |
GSTCD |
glutathione S-transferase, C-terminal domain containing |
chr17_-_41738931 | 1.72 |
ENST00000329168.3 ENST00000549132.1 |
MEOX1 |
mesenchyme homeobox 1 |
chr8_+_27183033 | 1.72 |
ENST00000420218.2 |
PTK2B |
protein tyrosine kinase 2 beta |
chr5_-_131826457 | 1.72 |
ENST00000437654.1 ENST00000245414.4 |
IRF1 |
interferon regulatory factor 1 |
chr14_+_88471468 | 1.71 |
ENST00000267549.3 |
GPR65 |
G protein-coupled receptor 65 |
chr19_-_47220335 | 1.71 |
ENST00000601806.1 ENST00000593363.1 ENST00000598633.1 ENST00000595515.1 ENST00000433867.1 |
PRKD2 |
protein kinase D2 |
chr12_+_11802753 | 1.70 |
ENST00000396373.4 |
ETV6 |
ets variant 6 |
chr14_-_35344093 | 1.70 |
ENST00000382422.2 |
BAZ1A |
bromodomain adjacent to zinc finger domain, 1A |
chr1_+_66797687 | 1.67 |
ENST00000371045.5 ENST00000531025.1 ENST00000526197.1 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
chr3_+_151986709 | 1.67 |
ENST00000495875.2 ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1 |
muscleblind-like splicing regulator 1 |
chr16_+_67063262 | 1.66 |
ENST00000565389.1 |
CBFB |
core-binding factor, beta subunit |
chr1_-_150669500 | 1.64 |
ENST00000271732.3 |
GOLPH3L |
golgi phosphoprotein 3-like |
chr17_+_43299241 | 1.63 |
ENST00000328118.3 |
FMNL1 |
formin-like 1 |
chr1_+_43766642 | 1.63 |
ENST00000372476.3 |
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr3_-_98241760 | 1.62 |
ENST00000507874.1 ENST00000502299.1 ENST00000508659.1 ENST00000510545.1 ENST00000511667.1 ENST00000394185.2 ENST00000394181.2 ENST00000508902.1 ENST00000341181.6 ENST00000437922.1 ENST00000394180.2 |
CLDND1 |
claudin domain containing 1 |
chr3_+_48507210 | 1.61 |
ENST00000433541.1 ENST00000422277.2 ENST00000436480.2 ENST00000444177.1 |
TREX1 |
three prime repair exonuclease 1 |
chr17_+_43299156 | 1.57 |
ENST00000331495.3 |
FMNL1 |
formin-like 1 |
chr19_+_36203830 | 1.53 |
ENST00000262630.3 |
ZBTB32 |
zinc finger and BTB domain containing 32 |
chr16_-_88717482 | 1.53 |
ENST00000261623.3 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr14_+_102276192 | 1.52 |
ENST00000557714.1 |
PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
chr15_-_55611306 | 1.50 |
ENST00000563262.1 |
RAB27A |
RAB27A, member RAS oncogene family |
chr2_+_231280908 | 1.50 |
ENST00000427101.2 ENST00000432979.1 |
SP100 |
SP100 nuclear antigen |
chr8_+_27182862 | 1.50 |
ENST00000521164.1 ENST00000346049.5 |
PTK2B |
protein tyrosine kinase 2 beta |
chr19_-_19754404 | 1.49 |
ENST00000587205.1 ENST00000445806.2 ENST00000203556.4 |
GMIP |
GEM interacting protein |
chr19_-_8642289 | 1.48 |
ENST00000596675.1 ENST00000338257.8 |
MYO1F |
myosin IF |
chr1_-_202129105 | 1.47 |
ENST00000367279.4 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
chr6_-_42016385 | 1.47 |
ENST00000502771.1 ENST00000508143.1 ENST00000514588.1 ENST00000510503.1 ENST00000415497.2 ENST00000372988.4 |
CCND3 |
cyclin D3 |
chr21_-_46340770 | 1.44 |
ENST00000397854.3 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr1_-_160549235 | 1.44 |
ENST00000368054.3 ENST00000368048.3 ENST00000311224.4 ENST00000368051.3 ENST00000534968.1 |
CD84 |
CD84 molecule |
chrX_+_37639264 | 1.44 |
ENST00000378588.4 |
CYBB |
cytochrome b-245, beta polypeptide |
chr16_-_88717423 | 1.43 |
ENST00000568278.1 ENST00000569359.1 ENST00000567174.1 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr16_-_68002456 | 1.43 |
ENST00000576616.1 ENST00000572037.1 ENST00000338335.3 ENST00000422611.2 ENST00000316341.3 |
SLC12A4 |
solute carrier family 12 (potassium/chloride transporter), member 4 |
chr11_+_22688150 | 1.42 |
ENST00000454584.2 |
GAS2 |
growth arrest-specific 2 |
chr3_+_113465866 | 1.41 |
ENST00000273398.3 ENST00000538620.1 ENST00000496747.1 ENST00000475322.1 |
ATP6V1A |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
chr9_+_77703414 | 1.40 |
ENST00000346234.6 |
OSTF1 |
osteoclast stimulating factor 1 |
chr8_+_74903580 | 1.40 |
ENST00000284818.2 ENST00000518893.1 |
LY96 |
lymphocyte antigen 96 |
chr12_+_98909260 | 1.36 |
ENST00000556029.1 |
TMPO |
thymopoietin |
chr1_+_161551101 | 1.35 |
ENST00000367962.4 ENST00000367960.5 ENST00000403078.3 ENST00000428605.2 |
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
chr2_+_97203082 | 1.35 |
ENST00000454558.2 |
ARID5A |
AT rich interactive domain 5A (MRF1-like) |
chr12_-_118797475 | 1.35 |
ENST00000541786.1 ENST00000419821.2 ENST00000541878.1 |
TAOK3 |
TAO kinase 3 |
chr3_+_20081515 | 1.35 |
ENST00000263754.4 |
KAT2B |
K(lysine) acetyltransferase 2B |
chr17_-_37934466 | 1.34 |
ENST00000583368.1 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
chr12_+_94071341 | 1.34 |
ENST00000542893.2 |
CRADD |
CASP2 and RIPK1 domain containing adaptor with death domain |
chr13_+_111806083 | 1.31 |
ENST00000375736.4 |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
chr13_+_111806055 | 1.30 |
ENST00000218789.5 |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
chr4_-_10117949 | 1.30 |
ENST00000508079.1 |
WDR1 |
WD repeat domain 1 |
chr11_+_65407331 | 1.30 |
ENST00000527525.1 |
SIPA1 |
signal-induced proliferation-associated 1 |
chr7_-_26904317 | 1.29 |
ENST00000345317.2 |
SKAP2 |
src kinase associated phosphoprotein 2 |
chr8_+_110552337 | 1.29 |
ENST00000337573.5 |
EBAG9 |
estrogen receptor binding site associated, antigen, 9 |
chr16_+_29674277 | 1.29 |
ENST00000395389.2 |
SPN |
sialophorin |
chr3_-_46249878 | 1.28 |
ENST00000296140.3 |
CCR1 |
chemokine (C-C motif) receptor 1 |
chr1_-_159894319 | 1.26 |
ENST00000320307.4 |
TAGLN2 |
transgelin 2 |
chr16_+_30484021 | 1.26 |
ENST00000358164.5 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr8_+_110551925 | 1.26 |
ENST00000395785.2 |
EBAG9 |
estrogen receptor binding site associated, antigen, 9 |
chr7_+_101928380 | 1.25 |
ENST00000536178.1 |
SH2B2 |
SH2B adaptor protein 2 |
chr11_+_1874200 | 1.24 |
ENST00000311604.3 |
LSP1 |
lymphocyte-specific protein 1 |
chr7_+_99971068 | 1.24 |
ENST00000198536.2 ENST00000453419.1 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
chr1_+_186798073 | 1.23 |
ENST00000367466.3 ENST00000442353.2 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr6_-_6007200 | 1.22 |
ENST00000244766.2 |
NRN1 |
neuritin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 17.8 | GO:0032010 | phagolysosome(GO:0032010) |
2.2 | 10.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.9 | 7.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.8 | 12.4 | GO:0043196 | varicosity(GO:0043196) |
1.4 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.3 | 8.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 5.2 | GO:0036398 | TCR signalosome(GO:0036398) |
1.0 | 6.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.0 | 20.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 5.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.8 | 9.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 9.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 5.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 8.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 5.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 9.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 7.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.4 | 2.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 4.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.3 | 2.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.3 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 1.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.3 | 1.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.3 | 6.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 1.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 3.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 2.7 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 9.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.8 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.2 | 0.6 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 3.2 | GO:0032059 | bleb(GO:0032059) |
0.2 | 13.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 2.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 4.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 1.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 18.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 9.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 26.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 4.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 3.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 4.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.1 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 17.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.0 | 2.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 18.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 3.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.3 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 5.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 3.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 3.0 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 4.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 5.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 3.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 3.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.8 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 1.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.9 | GO:0000793 | condensed chromosome(GO:0000793) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 33.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 51.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 9.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 30.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 4.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 22.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 22.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 10.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 14.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 24.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 4.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 11.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 11.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 17.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 18.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 4.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 13.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 7.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 4.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 5.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 18.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 7.9 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.7 | 17.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.7 | 10.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.6 | 11.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.6 | 4.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.5 | 19.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.3 | 24.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.1 | 12.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.1 | 3.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.0 | 3.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.9 | 6.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.9 | 14.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 15.3 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 3.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.7 | 4.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.6 | 1.9 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.6 | 1.9 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.6 | 16.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.6 | 17.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.6 | 7.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 1.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 2.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.5 | 2.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.5 | 2.0 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.5 | 3.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 5.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 5.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 7.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 7.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 2.3 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.4 | 2.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.4 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.3 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.3 | 5.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 4.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.3 | 5.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 6.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.3 | 1.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 1.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 0.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.3 | 0.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.3 | 7.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 11.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.0 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.2 | 0.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 3.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 3.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 4.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 8.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 5.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 7.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 3.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.5 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
0.2 | 4.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 5.8 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.6 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 1.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.6 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.1 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 3.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 3.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 2.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 12.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 6.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 1.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 2.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 3.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 2.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 9.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.0 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 5.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 4.0 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 1.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 6.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 2.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 2.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 1.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 4.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 1.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 1.0 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 3.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 6.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 1.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.9 | GO:0061733 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0030305 | heparanase activity(GO:0030305) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 3.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 26.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.9 | 25.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 16.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 31.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 5.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 23.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 39.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 16.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 14.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 10.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 8.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 6.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 3.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 4.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 6.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 3.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 4.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 5.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 4.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 13.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 6.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 14.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 4.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 2.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 1.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 1.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 17.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
3.6 | 10.9 | GO:0070666 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
3.6 | 14.5 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
2.5 | 19.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.4 | 11.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) bone marrow development(GO:0048539) |
2.1 | 12.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.9 | 7.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.8 | 12.4 | GO:0033590 | response to cobalamin(GO:0033590) |
1.6 | 7.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.6 | 6.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.5 | 9.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.5 | 4.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.2 | 3.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
1.1 | 5.3 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.0 | 5.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.0 | 7.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 4.5 | GO:2000630 | positive regulation of hyaluronan biosynthetic process(GO:1900127) positive regulation of miRNA metabolic process(GO:2000630) |
0.9 | 5.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 3.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.9 | 11.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 3.2 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.8 | 25.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.7 | 2.1 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.7 | 13.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 2.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.7 | 13.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.6 | 4.7 | GO:0043307 | eosinophil activation(GO:0043307) |
0.6 | 5.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.6 | 1.7 | GO:0061056 | sclerotome development(GO:0061056) |
0.6 | 1.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.6 | 4.0 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.5 | 1.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.5 | 7.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 2.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.0 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.5 | 2.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.5 | 7.9 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.5 | 0.5 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 2.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.4 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 6.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:0050880 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.4 | 1.9 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.4 | 5.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 0.8 | GO:0072683 | T cell extravasation(GO:0072683) |
0.4 | 5.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 0.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 2.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.4 | 1.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.3 | 4.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.0 | GO:0001300 | chronological cell aging(GO:0001300) |
0.3 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.3 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.3 | 8.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 1.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.3 | 1.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 25.6 | GO:0042100 | B cell proliferation(GO:0042100) |
0.3 | 2.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 6.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 7.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.3 | 1.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.4 | GO:0034127 | detection of lipopolysaccharide(GO:0032497) regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.3 | 0.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 2.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 2.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 3.1 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.3 | 21.4 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 2.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.3 | 5.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 5.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 1.0 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
0.2 | 2.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.2 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.2 | 1.2 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 3.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.2 | 5.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.1 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.2 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 4.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.6 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.2 | 0.6 | GO:1904744 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
0.2 | 4.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 7.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.2 | 1.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.2 | 0.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.2 | 2.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 3.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 3.2 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.8 | GO:1901029 | adenine transport(GO:0015853) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 1.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.6 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.2 | 1.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 3.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.6 | GO:0072299 | visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.1 | 0.6 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 7.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 0.6 | GO:0061358 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
0.1 | 0.6 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 1.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.5 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.1 | 0.9 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 1.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 1.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.8 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 14.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.5 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 2.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 0.9 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 1.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 1.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 2.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 15.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 14.2 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 0.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 1.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 1.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 1.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 3.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 1.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 1.4 | GO:0071404 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 16.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 1.9 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 5.6 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.8 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.8 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 1.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.4 | GO:1990592 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.3 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 1.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.0 | 0.2 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.0 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 1.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.0 | 0.6 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 1.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 1.7 | GO:0072431 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.5 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 1.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 3.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.5 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.4 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 2.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 1.0 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 1.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.2 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 1.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.6 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.8 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.5 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.3 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.2 | GO:0070997 | neuron death(GO:0070997) |
0.0 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 1.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.7 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 1.0 | GO:0060041 | retina development in camera-type eye(GO:0060041) |